U.S. Electrical Stock News

NasdaqGS:CPIX
NasdaqGS:CPIXPharmaceuticals

Cumberland Pharmaceuticals (CPIX) Stock Cools As Cash Rich Biotech Pivot Begins

Cumberland Pharmaceuticals stock cooled 2.8% today after a strong multi month run, even as the real story landed far from the trading screen. The headline is not the quarterly loss; it is the pivot. Q2 still showed a US$3.1 million operating loss on ongoing operations and a US$4.1 million net loss once discontinued activities are included. Yet the recently closed US$100 million divestiture and US$1.50 per share special dividend now frame Cumberland as a cash rich, development focused biotech...
NYSE:IR
NYSE:IRMachinery

Ingersoll Rand (IR) Could Be 3% Undervalued After Q2 Earnings And Guidance Update

Ingersoll Rand (IR) is back in focus after its second quarter 2026 earnings update, its new full year revenue growth guidance of 4.5% to 6.5%, and continued capital returns via buybacks and dividends. See our latest analysis for Ingersoll Rand. Ingersoll Rand's recent guidance update, Lone Star Blower acquisition, and ongoing buybacks appear to sit behind a solid run of momentum, with a 30 day share price return of 11.62% and a 1 year total shareholder return of 17.80% pointing to both short...
NYSE:GATX
NYSE:GATXTrade Distributors

GATX (GATX) Could Be 18% Undervalued After Earnings And Higher Guidance

Why GATX stock is back in focus after earnings and guidance update GATX (GATX) is attracting fresh attention after reporting higher second quarter revenue and net income, alongside updated 2026 earnings guidance that gives investors a clearer view of expected full year profitability. See our latest analysis for GATX. Alongside the earnings and higher 2026 guidance, GATX stock has cooled slightly in the very near term, with the 1 day and 7 day share price returns both declining a little over...
NYSE:OSCR
NYSE:OSCRInsurance

What Does Oscar Health (OSCR) Joining ICHRAx Mean For Its Growth?

Oscar Health (NYSE:OSCR) has joined the initial industry cohort for ICHRAx, a new platform focused on standardizing individual coverage health reimbursement arrangement enrollment and billing. ICHRAx is designed to simplify how employers and employees manage ICHRA plans across insurers using a common technology framework. Participation in the ICHRAx launch positions Oscar Health as an early contributor to efforts to streamline administration in the individual coverage market. The move is...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter (BAX) Stock May Be 25% Undervalued As Q2 Outlook Improves

Baxter International has climbed back into positive territory over the last year, yet the stock still carries a long 5 year track record of losses. Investors are asking whether the recent rebound and fresh optimism around the business are now fully reflected in the share price, or if there is still a margin between market price and intrinsic value based on a Discounted Cash Flow (DCF) view. Over the last 5 years Baxter International has declined 59.1%, which means the stock is coming into...
NasdaqGS:UAL
NasdaqGS:UALAirlines

Why United Airlines (UAL) Is Up 11.2% After Massive $20 Billion Dulles Hub Modernization Plan

In July 2026, the Metropolitan Washington Airports Authority, United Airlines, and the U.S. Department of Transportation announced a more than US$20.00 billion, decade-long modernization of Washington Dulles International Airport, adding over 5.00 million square feet of new and upgraded facilities while retiring the airport’s mobile lounge vehicles. This large-scale capital program deepens United’s role at a key U.S. gateway, with new United gates, expanded lounge capacity, and upgraded...
NYSE:ORC
NYSE:ORCMortgage REITs

Is Orchid Island’s Q2 Profit Swing And Major Buybacks Altering The Investment Case For ORC?

In July 2026, Orchid Island Capital, Inc. reported second-quarter 2026 results showing net income of US$89.19 million and basic earnings per share from continuing operations of US$0.44, compared with a loss a year earlier. Over the same period, the company also continued its long-running share repurchase effort, buying back more than one million shares and completing a program that has retired very large portion of its outstanding stock since 2015. Next, we’ll examine how this sharp swing to...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Is Sprouts Farmers Market (SFM) Undervalued On Q2 Results And 2026 Store Plans?

Sprouts Farmers Market (SFM) just packed a lot into a single update. The company reported second quarter results, issued fresh guidance for 2026, expanded its store opening plan, and announced the completion of a share repurchase tranche. See our latest analysis for Sprouts Farmers Market. Sprouts Farmers Market shares trade at US$85.12 after a recent 7.53% 7 day share price return, while the 1 year total shareholder return has fallen 43.54% and the 5 year total shareholder return is 244.48%...
NasdaqGS:SOFI
NasdaqGS:SOFIConsumer Finance

Why SoFi (SOFI) Is Up 19.7% After Strong Q2 Profit And New Private Market Funds

In late July 2026, SoFi Technologies reported second-quarter revenue of US$1,140.53 million and net income of US$156.59 million, alongside higher net charge-offs of US$204.51 million, reflecting both growth in its lending activity and credit costs. In early August 2026, SoFi expanded its SoFi Invest lineup with three new CAZ Investments and AngelList private market funds, broadening member access to alternative assets across AI, fintech, healthcare, defense, and other sectors with relatively...
NasdaqGM:KYMR
NasdaqGM:KYMRBiotechs

Kymera Therapeutics (KYMR) Stock Faces A Revenue Durability Reckoning

Kymera Therapeutics stock edged up about 1% to US$105.48 after the Q2 print, a muted move for a biotech reporting US$65m in collaboration revenue and another quarter of sizeable losses. The market seems to be treating this as a steady, low drama update rather than a breakout moment. The key point for investors is the widening gap between a partnership-driven top line and continuing net losses of more than US$60m for the quarter. With cash of about US$1.5b and no more collaboration revenue...
NasdaqCM:SEZL
NasdaqCM:SEZLDiversified Financial

Is Sezzle (SEZL) Using AI-Powered Scale To Quietly Redraw Its Risk-Reward Profile?

In early August 2026, Sezzle Inc. highlighted expectations for its second-quarter 2026 results, pointing to ongoing growth momentum driven by higher purchase frequency, rising subscriber numbers, and broader merchant adoption of its platform and Pay-in-5 offering. An interesting angle is how Sezzle’s emphasis on efficient customer acquisition and AI-enabled operating leverage may help counterbalance margin pressure from heavier marketing and normalizing credit provisions. Next, we’ll examine...
NYSE:PSA
NYSE:PSASpecialized REITs

Welltower Stock And Other REITs Facing A Mean Reversion Test

With S&P 500 futures pressing against a key resistance zone and traders watching for either a breakout or a sharp mean reversion, short-term moves in large-cap U.S. stocks are under an intense spotlight. This kind of setup can create sudden winners and sudden laggards, which is why it matters if you care about timing. This article walks through 3 stocks exposed to the current news-driven tension around profit-taking and potential pullbacks. The 3 stocks below are just a starting sample, and...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Recalls Hundreds Of Thousands Of Devices As FDA Flags Software Issue

Boston Scientific (NYSE:BSX) has initiated multiple large-scale recalls of cardiac ablation and access devices affecting hundreds of thousands of units globally in late July and August 2026. An FDA enforcement report cites a software anomaly in the TheraSphere 360 radiological platform, adding to the recent wave of product safety actions. The cluster of recalls and the FDA software enforcement report comes shortly after Boston Scientific's latest earnings and guidance updates. Consider...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Maplebear (CART) After Earnings Optimism And Caper Cart Expansion Looks Undervalued

Maplebear (CART) is back in focus after fresh earnings projections and sentiment shifts, while its Instacart unit’s AI-powered Caper smart trolleys with UK grocer Morrisons add an extra angle to the stock’s story. See our latest analysis for Maplebear. At a share price of US$45.35, Maplebear has given investors a 90 day share price return of 19.37%, while the 1 year total shareholder return is down 4.97%. This suggests that recent momentum has picked up after a softer year. If you are...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

3 Utility Stocks With Steady Dividends As Rate Pressure Builds

With the Federal Reserve debating its next move and markets bracing for the possibility of higher rates, many investors are rethinking how they get reliable income from stocks. Rising borrowing costs and inflation worries can unsettle growth stories, yet they also shine a spotlight on companies that focus on steady dividends and durable cash flows. This article walks through three stocks from a Defensive Dividend Stocks screener that appear positively exposed to the current rate backdrop and...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

Tower Semiconductor (TSEM) Could Be 33% Below Fair Value Following Record Q2 Results

Tower Semiconductor (TSEM) has attracted fresh attention after reporting record Q2 2026 revenue of US$460.08 million and net income of US$90.77 million, along with guidance for a new revenue high in Q3. See our latest analysis for Tower Semiconductor. Tower Semiconductor’s latest results have arrived after a period of sharp gains and some recent volatility, with a 1-year total shareholder return above 300% and year to date share price return of 73.44% suggesting strong momentum despite a...
NYSE:BKH
NYSE:BKHIntegrated Utilities

Is Black Hills (BKH) A Bargain As Q2 Earnings Lifted Profitability?

Q2 earnings event puts Black Hills in focus Black Hills (BKH) is in the spotlight after reporting second quarter 2026 results on August 5, with higher net income and earnings per share from continuing operations compared with a year earlier. See our latest analysis for Black Hills. Despite Black Hills reporting higher net income and earnings per share for the quarter and affirming its quarterly dividend on July 28, the stock shows mixed momentum, with a 1-year total shareholder return of...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Cisco (CSCO) Stock Looks Fairly Valued Despite Strong AI Hopes

Cisco Systems has delivered very strong share price gains over the past five years, and at around US$121.50 the stock now screens as roughly in line with its intrinsic value estimate from a Discounted Cash Flow (DCF) model rather than clearly cheap or clearly expensive. Cisco Systems has returned about 150.1% over the past 5 years, which puts extra focus on whether the current valuation still leaves enough room for long term returns. Expectations around demand for AI infrastructure and...
NasdaqCM:DVLT
NasdaqCM:DVLTSemiconductor

Datavault AI (DVLT) Could Be 89% Undervalued Following Its Expanded DataMeds Deal

Datavault AI (DVLT) is back on investor screens after amending its agreement with DataMeds AI to expand PharmacyChain licensing into broader healthcare and wellness, while restructuring its stake into common shares categorized as revenue. See our latest analysis for Datavault AI. Despite the expanded DataMeds AI agreement and recent management and investor events, Datavault AI’s short term momentum remains weak, with the share price down 24% in the last day and 72% year to date, alongside...
NYSE:HIG
NYSE:HIGInsurance

Hartford Insurance Group (HIG) Looks Fairly Valued After Earnings Buyback And Benefits Deal

Why Hartford Insurance Group stock is in focus now Hartford Insurance Group (HIG) is back on investor radar after reporting second quarter 2026 results, updating its share repurchase activity and outlining a new buyback authorization alongside an acquisition in employee benefits. See our latest analysis for Hartford Insurance Group. Hartford Insurance Group’s latest earnings, buyback update and the planned acquisition of Equitable’s Employee Benefits business come after a period where the...
NYSE:XOM
NYSE:XOMOil and Gas

ExxonMobil Holdings (XOM) Could Be 11% Undervalued After Blowout Q2 Earnings

ExxonMobil Holdings (XOM) is back in focus after reporting second quarter 2026 earnings tied to high oil prices, record refining margins, and an unusually sharp political backlash over wartime fuel profits. See our latest analysis for ExxonMobil Holdings. ExxonMobil Holdings' share price has pulled back slightly in the last week after the earnings release and political criticism. However, the year to date share price return of 23.63% and 1 year total shareholder return of 46.90% still point...
NYSE:DEI
NYSE:DEIOffice REITs

Douglas Emmett (DEI) Stock Sees Interest Costs Eclipse Steady FFO

Douglas Emmett stock slipped 1.3% today to about US$11.80, which is a muted move for a real estate investment trust that just posted another quarter of unprofitable earnings. The emotional drag is clear. Investors are fixating on the reported loss per share and the weight of higher interest costs, while the core real estate engine tells a more balanced story. The real action sits in funds from operations and cash generation. Funds From Operations held in the mid US$70m range in the quarter...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland-Cliffs (CLF) Is Up 11.2% After Narrowing Q2 Losses And Pausing Buybacks - What's Changed

In the second quarter of 2026, Cleveland-Cliffs Inc. reported sales of US$5,226 million and a net loss of US$145 million, both improved from a year earlier, while executing no additional share repurchases under its April 2024 buyback program. The results show sales growth alongside a smaller loss per share, indicating that cost and operational measures are narrowing the company’s losses even as it pauses incremental buybacks. With quarterly losses narrowing and sales higher, we’ll now...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

Why Viavi Solutions (VIAV) Is Up 20.7% After Strong Q4 Profit Beat And Revenue Guidance

In August 2026, Viavi Solutions Inc. reported fourth-quarter fiscal 2026 results showing sales of US$443.1 million and net income of US$32.7 million, and issued first-quarter fiscal 2027 net revenue guidance of US$450 million to US$460 million. While the full year still showed a net loss of US$30.4 million, the latest quarter’s stronger profitability and continued outperformance versus earnings estimates highlighted improving operational momentum. We’ll now examine how Viavi’s stronger...